The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016 / Antinori, Andrea; Di Biagio, Antonio; Marcotullio, Simone; Andreoni, Massimo; Chirianni, Antonio; d'Arminio Monforte, Antonella; Galli, Massimo; Mazzotta, Francesco; Mussini, Cristina; Puoti, Massimo; Lazzarin, Adriano; Italian HIV Guidelines Working, Group; Mastroianni, C. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017), pp. 86-98.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

Mastroianni, C
Membro del Collaboration Group
2017

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.
2017
guidelines; hiv; italy; antiretroviral agents; anti-hiv agents; drug administration schedule; drug therapy, combination; hiv infections; health policy; italy; hiv-1; practice guidelines as topic
01 Pubblicazione su rivista::01a Articolo in rivista
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016 / Antinori, Andrea; Di Biagio, Antonio; Marcotullio, Simone; Andreoni, Massimo; Chirianni, Antonio; d'Arminio Monforte, Antonella; Galli, Massimo; Mazzotta, Francesco; Mussini, Cristina; Puoti, Massimo; Lazzarin, Adriano; Italian HIV Guidelines Working, Group; Mastroianni, C. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017), pp. 86-98.
File allegati a questo prodotto
File Dimensione Formato  
Antinori_Italian_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 496.68 kB
Formato Adobe PDF
496.68 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1136436
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
social impact